This is what could keep you out of the hospital if you take COVID-19 – BGR

by

  • The latest coronavirus update conducted by researchers at Johns Hopkins University shows that more than 17.9 million cases of coronavirus have been reported in the U.S. since the time of writing.
  • Public health officials say antibodies to Eli Lilly and Regeneron’s antibodies could drastically reduce coronavirus hospitalizations.
  • However, the launch of these coronavirus antibody drugs has been unmatched, at best.

So much importance has been given to the ongoing deployment of coronavirus vaccines in the United States right now by drug manufacturers like Pfizer and Moderna, but there is another COVID treatment that is already close that is being heavily underused.

According to federal health officials, such as U.S. Secretary of Health Alex Azar, and Moncef Slaoui, chief scientific adviser to the federal government’s Operation Warp Speed ​​vaccine program. They refer to antibody drugs from pharmaceutical giants like Eli Lilly and Regeneron, which can reduce coronavirus hospitalization by half or more. However, new reports show that while about 65,000 doses of the drugs are distributed each week in the states, only between 5% and 20% are used.

Today’s offer Amazon has a rare discount on Purell hand sanitizer pump bottles you can’t find in stores yet List price:$ 75.60 Price:$ 64.99 ($ ​​0.68 / oz) Save:$ 10.61 (14%) Available on Amazon, BGR may receive a commission Buy now Available on Amazon BGR may receive a commission

The latter is according to Slaoui, who said in an interview with CNBC that use should be “much more” because these drugs intended for patients at high risk of contracting a severe form of COVID-19 could reduce hospitalizations by up to 70%. Likewise, Chance, from an interview with CNBC Shepard Smith a few days ago: “We have a surplus of these monoclonal antibodies right now. What happens is that people wait too long to look for treatments.

These comments come as more than half a million coronavirus vaccines have been administered in the United States since the time of writing, according to From Bloomberg vaccine tracker. But there is still much more work to be done along these lines, as these data showed that so far no state has vaccinated even 1% of its population, although some states are close. Meanwhile, the latest coronavirus data from Johns Hopkins University shows that to date more than 17.9 million cases of coronavirus have been found in the United States and more than 318,000 people in the United States have died from this coronavirus.

The amount of antibody drugs has increased in recent weeks, from scarcity to surplus, as the pandemic has continued to ravage the United States.

“If you are over 65 or at risk for serious complications or hospitalization due to comorbidities, what do you have and what do you test positive for, you should look for and get the Lilly or Regeneron monoclonal antibody,” Azar said. News with Shepard Smith. “It can drastically reduce the risk for us of hospitalizations at a time when hospitals are enjoying people with COVID.”

What is worrying about how the release of these drugs has been so erratic, is that it can be a disastrous omen of how far, or not, such a large deployment of the coronavirus vaccine will go all over the world. country. For antibody drugs, a specific infrastructure needs to be established and installed to administer them to people. Some states use all the allocation they get from the federal government, while others, according to former FDA commissioner Dr. Scott Gottlieb, they might not use any assignment.

Andy is a reporter in Memphis who also contributes to outlets such as Fast Company and The Guardian. When he’s not writing about technology, he can be found crouching down with protection over his growing vinyl collection, in addition to taking care of his whovianism and indulging in various TV shows you probably don’t like.

.Source

Leave a Comment